Clinical Trial Update: Ertapenem Pharmacokinetics in Patients in Continuous Ambulatory Peritoneal Dialysis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the pharmacokinetics of ertapenem in patients undergoing continuous ambulatory peritoneal dialysis due to end-stage renal dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Invanz (ertapenem)

Snippet

Sponsor: Albany College of Pharmacy and Health Sciences | Conditions: Continuous Ambulatory Peritoneal Dialysis, End Stage Renal Disease | Phase 4 | Status: COMPLETED | Results posted: 2013-02-26